K. Takeuchi et al., INFLUENCES OF URETHANE ANESTHESIA ON INDOMETHACIN-INDUCED GASTRIC-MUCOSAL LESIONS IN RATS - RELATION TO BLOOD-GLUCOSE LEVELS, Digestive diseases and sciences, 39(12), 1994, pp. 2536-2542
Effects of urethane on gastric motility and mucosal ulcerogenic respon
ses induced by indomethacin were investigated in the rat in relation t
o blood glucose levels (BGL) and compared with those of pentobarbital
Na. Urethane (1.25 g/kg) given intraperitoneally, caused a progressive
and significant rise in BGL, while pentobarbital (30 mg/kg) given int
raperitoneally did not affect BGL. Subcutaneous administration of indo
methacin (25 mg/kg) caused high-amplitude gastric contractions and ind
uced hemorrhagic lesions in the stomachs. of conscious rats. These les
ions were significantly inhibited by urethane but not pentobarbital. A
dministration of urethane abolished basal gastric motility and almost
completely suppressed the motility responses induced by indomethacin,
while pentobarbital did not have much effect on gastric motility under
basal and indomethacin-stimulated conditions. Acid secretion was sign
ificantly decreased by urethane and increased by pentobarbital. Pretre
atment of the animals with yohimbine (5 mg/kg, subcutaneously) but not
prazosin (0.5 mg/kg) inhibited the elevation in BGL seen after admini
stration of urethane and allowed resumption both gastric motility and
ulcerogenic responses induced by indomethacin, with less change in aci
d secretion. These results suggest that intraperitoneal administration
of urethane prevented indomethacin-induced gastric lesions, probably
by inhibiting the enhanced gastric motility response, and this effect
may relate to its hyperglycemic action mediated by alpha(2)-adrenocept
ors, These findings also provide further evidence to support the impor
tance of gastric motility in the pathogenesis of these lesions.